plasma balance mean concentration
Showing 1 - 25 of >10,000
Breast Cancer Trial in Suzhou ([14C] TQB3616)
Not yet recruiting
- Breast Cancer
- [14C] TQB3616
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 21, 2023
Mass Balance Study in Healthy Subjects Trial in Suzhou ([14C]JAB-21822)
Not yet recruiting
- Mass Balance Study in Healthy Subjects
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jun 25, 2023
Vascular Leakage During Systemic Inflammatory Response Syndrome
Not yet recruiting
- Systemic Inflammatory Response Syndrome
- Blood sampling
-
Paris, FranceMedical Intensive Care Unit, Georges Pompidou European Hospital
Dec 30, 2022
Phase 1 Study, Healthy Volunteers Trial in Beijing ([14C]DWP14012)
Active, not recruiting
- Phase 1 Study, Healthy Volunteers
-
Beijing, ChinaBeijing GoBroad Boren Hospital
May 11, 2023
Primary Mild and Moderate Hypertension Trial in Suzhou (SPH3127)
Completed
- Primary Mild and Moderate Hypertension
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 6, 2022
Healthy Volunteers Trial in Lincoln (TAK-935 Oral Tablet, [14C]TAK-935 IV Infusion, [14C]TAK-935 Oral Solution)
Completed
- Healthy Volunteers
- TAK-935 Oral Tablet
- +2 more
-
Lincoln, NebraskaCelerion
Oct 1, 2021
Occurrence and Concentrations of Ibrutinib and Idelalisib
Completed
- Hematological Malignancies
- Blood samples for pharmacokinetics exploration
- +7 more
-
Toulouse, FranceCancer University Institute of Toulouse Oncopole
Dec 24, 2020
Venetoclax Plasma Concentration and Remission in Acute Myeloid
Not yet recruiting
- Adult Acute Myeloid Leukemia
- Blood sampling for venetoclax drug dosage (venous puncture)
- (no location specified)
Sep 13, 2023
Chronic Kidney Diseases, Magnetic Resonance Imaging Trial in Suzhou (TQ-B3525)
Not yet recruiting
- Chronic Kidney Diseases
- Magnetic Resonance Imaging
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jan 10, 2023
End Stage Renal Disease on Dialysis Trial in Aarhus (Low dialysate temperature, High dialysate temperature, Low dialysate
Completed
- End Stage Renal Disease on Dialysis
- Low dialysate temperature
- +3 more
-
Aarhus, Region Midt, DenmarkDialysis Clinic at Department of Renal Medicine, Aarhus Universi
May 17, 2022
Small Cell Lung Cancer Trial in Suzhou (Chiauranib)
Recruiting
- Small Cell Lung Cancer
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Suzhou University
Jul 19, 2022
Postoperative Gastrointestinal Dysfunction After High Risk
Recruiting
- Gastrointestinal Dysfunction
- +2 more
-
Jakarta Pusat, Jakarta, IndonesiaCipto Mangunkusumo Central National Hospital
May 10, 2023
Colorectal Cancer, Urologic Cancer, Gynecologic Cancer Trial (acetated Ringers, albumin 5%, albumin 20%)
Not yet recruiting
- Colorectal Cancer
- +4 more
- acetated Ringers
- +2 more
- (no location specified)
Feb 9, 2023
Healthy Volunteers Trial in Lincoln (TAK-831 Oral Tablet, [14C]TAK-831 IV Infusion, [14C]TAK-831 Oral Suspension)
Completed
- Healthy Volunteers
- TAK-831 Oral Tablet
- +2 more
-
Lincoln, NebraskaCelerion
Jun 9, 2021
Healthy Adult Male Trial in Leeds ((14C)-OPC-61815)
Completed
- Healthy Adult Male
-
Leeds, United KingdomCovance Clinical Research Unit Ltd
Sep 8, 2021
Vitamin A Trial in Dakar (Intervention)
Not yet recruiting
- Vitamin A
- Intervention
-
Dakar, SenegalUniversite Cheikh Anta Diop
Nov 8, 2022
Influenza, Human Trial (ZX-7101A 80mg)
Not yet recruiting
- Influenza, Human
- ZX-7101A 80mg
- (no location specified)
Feb 6, 2023
Type 1 Diabetes Trial in Copenhagen (Rapidly declining plasma glucose, Slowly declining plasma glucose)
Active, not recruiting
- Type 1 Diabetes
- Rapidly declining plasma glucose
- Slowly declining plasma glucose
-
Copenhagen, DenmarkSteno Diabetes Center Copenhagen - Gentofte Hospital
May 12, 2022
Salivary Oxidant and Antioxidant Levels in Peri-implant Health
Completed
- Peri-Implantitis
- +4 more
- (no location specified)
Feb 2, 2023
Healthy Trial (BI 1810631 (C-14) formulation 1, BI 1810631, BI 1810631 (C-14) formulation 2)
Not yet recruiting
- Healthy
- BI 1810631 (C-14) formulation 1
- +2 more
- (no location specified)
May 25, 2023
Gastroscopy Trial in Chengdu (other, procedure, drug)
Completed
- Gastroscopy
- Bispectral index
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital
Mar 15, 2023
Healthy Male Subjects Trial in Tokyo ([14C] TS-142)
Completed
- Healthy Male Subjects
- [14C] TS-142
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022